by mcwebmaster | Jan 18, 2018
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The report measures action taken in four areas: research and science, access,...
by mcwebmaster | May 18, 2017
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance. The AMR Industry Alliance will ensure that signatories collectively...
by mcwebmaster | Sep 20, 2016
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance Represents major milestone following...
by mcwebmaster | Jan 21, 2016
More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in parallel in taking comprehensive action against drug-resistant...
